JPRN-UMIN000043565Recruiting未知
A prospective observational study of T cell subsets after administration of immune checkpoint inhibitors in patients with lung cancer - pharmacodynamics analysis based on T cell subsets of immune checkpoint inhibitors in patients with lung cancer
Kobe City Medical Center General Hospital0 sites50 target enrollmentStarted: March 9, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •inappropriate by the investigator and the investigator
Investigators
Similar Trials
Completed
Not Applicable
Evaluation of the immune system in older adults that receive a nutritional complement enriched with beta glucans extracted from the fungus Ganoderma lucidumImprovement in the baseline levels of immune system components in older adults.ISRCTN53126301Progal-BT SAS50
Completed
Not Applicable
Evaluation of the immune system in children aged 3 to 5 that receive a nutritional complement enriched with beta glucans extracted from the fungus Ganoderma lucidumISRCTN29923286Progal-BT SAS50
Completed
Not Applicable
Study of evaluating T cells subsets and cytokines in Phase II clinical trial of Tamibarotene (AM80G) for chronic graft-versus-host diseaseJPRN-UMIN000020364Okayama University Hospital18
Completed
Not Applicable
A pilot study to characterize T cell responses in young children after influenza infectio10047438influenzaNL-OMON33577niversitair Medisch Centrum Utrecht125
Completed
Not Applicable
An initial study to determine the T lymphocyte response in seriously ill COVID-19 patients: An observational study in Pune, IndiaCTRI/2021/03/032028Dr D Y Patil Vidyapeeth Pune137